Transcatheter aortic valve replacement: potential use in lower-risk aortic stenosis

References

• Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363(17):1597–1607.
   PubMed Web of Science ®Google Scholar
• Leon MB, Smith CR, Mack MJ, et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2016;374(17):1609–1620.
   PubMed Web of Science ®Google Scholar
• Reardon MJ, Van Mieghem NM, Popma JJ, et al. Surgical or transcatheter aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2017;376(14):1321–1331.
   PubMed Web of Science ®Google Scholar
• Thyregod HGH, Steinbrüchel DA, Ihlemann N, et al. Transcatheter versus surgical aortic valve replacement in patients with severe aortic valve stenosis: 1-year results from the all-comers NOTION randomized clinical trial. J Am Coll Cardiol. 2015;65(20):2184–2194.
   PubMed Web of Science ®Google Scholar
• Thyregod HGH, Ihlemann N, Jørgensen TH, et al. Five-year clinical and echocardiographic outcomes from the NOTION randomized clinical trial in patients at lower surgical risk. Circulation. 2019;139(24):2714–2723.
   PubMed Web of Science ®Google Scholar
• Mack MJ, Leon MB, Thourani VH, et al. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med. 2019;380(18):1695–1705.
   PubMed Web of Science ®Google Scholar
• Popma JJ, Michael Deeb G, Yakubov SJ, et al. Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients. N Engl J Med. 2019;380(18):1706–1715.
   PubMed Web of Science ®Google Scholar
• Gagne JJ, Glynn RJ, Avorn J, et al. A combined comorbidity score predicted mortality in elderly patients better than existing scores. J Clin Epidemiol. 2011;64(7):749–759.
   PubMed Web of Science ®Google Scholar
• Stortecky S, Schoenenberger AW, Moser A, et al. Evaluation of multidimensional geriatric assessment as a predictor of mortality and cardiovascular events after transcatheter aortic valve implantation. JACC Cardiovasc Interv. 2012;5(5):489–496.
   PubMed Web of Science ®Google Scholar
• Michelena HI, Prakash SK, Della CA, et al. Bicuspid aortic valve identifying knowledge gaps and rising to the challenge from the international bicuspid aortic valve consortium (BAVCON). Circulation. 2014;129(25):2691–2704.
   PubMed Web of Science ®Google Scholar
• Jilaihawi H, Chen M, Webb J, et al. A bicuspid aortic valve imaging classification for the TAVR era. JACC Cardiovasc Imaging. 2016;9(10):1145–1158.
   PubMed Web of Science ®Google Scholar
• Patel A, Leon MB. Transcatheter aortic valve replacement in patients with bicuspid aortic valves. J Thorac Dis. 2018;10(Suppl 30):S3568–S3572.
   PubMedGoogle Scholar
• Mangieri A, Tchetchè D, Kim WK, et al. Balloon versus self-expandable valve for the treatment of bicuspid aortic valve stenosis: insights from the BEAT international collaborative registries. Circ Cardiovasc Interv. 2020;13(7):e008714.
   PubMed Web of Science ®Google Scholar
• Tchetche D, De Biase C, Van Gils L, et al. Bicuspid aortic valve anatomy and relationship with devices: the bavard multicenter registry: A European picture of contemporary multidetector computed tomography sizing for bicuspid valves. Circ Cardiovasc Interv. 2019;12(1):1–10.
   Web of Science ®Google Scholar
• Waksman R, Craig PE, Torguson R, et al. Transcatheter aortic valve replacement in low-risk patients with symptomatic severe bicuspid aortic valve stenosis. JACC Cardiovasc Interv. 2020;13(9):1019–1027.
   PubMed Web of Science ®Google Scholar
• Ribeiro HB, Webb JG, Makkar RR, et al. Predictive factors, management, and clinical outcomes of coronary obstruction following transcatheter aortic valve implantation: insights from a large multicenter registry. J Am Coll Cardiol. 2013;62(17):1552–1562.
   PubMed Web of Science ®Google Scholar
• Khalique OK, Hahn RT, Gada H, et al. Quantity and location of aortic valve complex calcification predicts severity and location of paravalvular regurgitation and frequency of post-dilation after balloon-expandable transcatheter aortic valve replacement. JACC Cardiovasc Interv. 2014;7(8):885–894.
   PubMed Web of Science ®Google Scholar
• Pollari F, Dell’Aquila AM, Söhn C, et al. Risk factors for paravalvular leak after transcatheter aortic valve replacement. J Thorac Cardiovasc Surg. 2019;157(4):1406–1415.e3.
   PubMed Web of Science ®Google Scholar
• Pibarot P, Hahn RT, Weissman NJ, et al. Association of paravalvular regurgitation with 1-year outcomes after transcatheter aortic valve replacement with the SAPIEN 3 valve. JAMA Cardiol. 2017;2(11):1208–1216.
   PubMed Web of Science ®Google Scholar
• Barbanti M, Yang T-H, Rodès Cabau J, et al. Anatomical and procedural features associated with aortic root rupture during balloon-expandable transcatheter aortic valve replacement. Circulation. 2013;128(3):244–253.
   PubMed Web of Science ®Google Scholar
• Pollari F, Hitzl W, Vogt F, et al. Aortic valve calcification as a risk factor for major complications and reduced survival after transcatheter replacement. J Cardiovasc Comput Tomogr. 2020;14(4):307–313.
   PubMed Web of Science ®Google Scholar
• Fadahunsi OO, Olowoyeye A, Ukaigwe A, et al. Incidence, predictors, and outcomes of permanent pacemaker implantation following transcatheter aortic valve replacement: analysis from the U.S. Society of Thoracic Surgeons/American College of Cardiology TVT registry. JACC Cardiovasc Interv. 2016;9(21):2189–2199.
   PubMed Web of Science ®Google Scholar
• Pollari F, Großmann I, Vogt F, et al. Risk factors for atrioventricular block after transcatheter aortic valve implantation: A single-centre analysis including assessment of aortic calcifications and follow-up. Europace. 2019;21(5):787–795.
   PubMed Web of Science ®Google Scholar
• Maeno Y, Abramowitz Y, Kawamori H, et al. A highly predictive risk model for pacemaker implantation after TAVR. JACC Cardiovasc Imaging. 2017;10(10):1139–1147.
   PubMed Web of Science ®Google Scholar
• Mangieri A, Lanzillo G, Bertoldi L, et al. Predictors of advanced conduction disturbances requiring a late (≥48 H) permanent pacemaker following transcatheter aortic valve replacement. JACC Cardiovasc Interv. 2018;11(15):1519–1526.
   PubMed Web of Science ®Google Scholar
• Lanz J, Greenbaum A, Pilgrim T, et al. Current state of alternative access for transcatheter aortic valve implantation. EuroIntervention. 2018;14(AB):AB40–AB52.
   PubMedGoogle Scholar
• Van Belle E, Juthier F, Susen S, et al. Postprocedural aortic regurgitation in balloon-expandable and self-expandable transcatheter aortic valve replacement procedures: analysis of predictors and impact on long-term mortality: insights from the France2 registry. Circulation. 2014;129(13):1415–1427.
   PubMed Web of Science ®Google Scholar
• Kodali S, Pibarot P, Douglas PS, et al. Clinical RESEARCH paravalvular regurgitation after transcatheter aortic valve replacement with the Edwards sapien valve in the PARTNER trial: characterizing patients and impact on outcomes. Eur Heart J. 2015;36:449–456.
   PubMed Web of Science ®Google Scholar
• Saia F, Gandolfo C, Palmerini T, et al. In-hospital and thirty-day outcomes of the SAPIEN 3 ultra balloon-expandable transcatheter aortic valve: the S3U registry. EuroIntervention. 2020;15(14):1240–1247.
   PubMed Web of Science ®Google Scholar
• Van Mieghem NM, Wöhrle J, Hildick-Smith D, et al. Use of a repositionable and fully retrievable aortic valve in routine clinical practice: the RESPOND study and RESPOND extension cohort. JACC Cardiovasc Interv. 2019;12(1):38–49.
   PubMed Web of Science ®Google Scholar
• Möllmann H, Hengstenberg C, Hilker M, et al. Real-world experience using the ACURATE neo prosthesis: 30-day outcomes of 1,000 patients enrolled in the SAVI TF registry. EuroIntervention. 2018;13(15):e1764–e1770.
   PubMed Web of Science ®Google Scholar
• Makkar RR, Thourani VH, Mack MJ, et al. Five-year outcomes of transcatheter or surgical aortic-valve replacement. N Engl J Med. 2020;382(9):799–809.
   PubMed Web of Science ®Google Scholar
• Van Belle E, Vincent F, Labreuche J, et al. Balloon-expandable versus self-expanding transcatheter aortic valve replacement: a propensity-matched comparison from the FRANCE-TAVI registry. Circulation. 2020;141(4):243–259.
   PubMed Web of Science ®Google Scholar
• Zoghbi WA, Asch FM, Bruce C, et al. Guidelines for the evaluation of valvular regurgitation after percutaneous valve repair or replacement: a report from the American Society of Echocardiography developed in collaboration with the society for cardiovascular angiography and interventions, Japanese Society Of Echocardiography, And Society For Cardiovascular Magnetic Resonance. J Am Soc Echocardiogr. 2019;32(4):431–475.
   PubMed Web of Science ®Google Scholar
• Akodad M, Lefèvre T. TAVI: simplification is the ultimate sophistication. Front Cardiovasc Med. 2018;5. DOI:10.3389/fcvm.2018.00096
   PubMed Web of Science ®Google Scholar
• Villablanca PA, Mohananey D, Nikolic K, et al. Comparison of local versus general anesthesia in patients undergoing transcatheter aortic valve replacement: A meta-analysis. Catheter Cardiovasc Interv. 2018;91(2):330–342.
   PubMed Web of Science ®Google Scholar
• Mangieri A, Montalto C, Pagnesi M, et al. TAVI and post procedural cardiac conduction abnormalities. Front Cardiovasc Med. 2018;5. DOI:10.3389/fcvm.2018.00085.
   PubMed Web of Science ®Google Scholar
• Chamandi C, Barbanti M, Munoz-Garcia A, et al. Long-term outcomes in patients with new permanent pacemaker implantation following transcatheter aortic valve replacement. JACC Cardiovasc Interv. 2018;11(3):301–310.
   PubMed Web of Science ®Google Scholar
• Erkapic D, De Rosa S, Kelava A, et al. Risk for permanent pacemaker after transcatheter aortic valve implantation: A comprehensive analysis of the literature. J Cardiovasc Electrophysiol. 2012;23(4):391–397.
   PubMed Web of Science ®Google Scholar
• Huded CP, Tuzcu EM, Krishnaswamy A, et al. Association between transcatheter aortic valve replacement and early postprocedural stroke. J Am Med Assoc. 2019;321(23):2306–2315.
   PubMed Web of Science ®Google Scholar
• Haussig S, Mangner N, Dwyer MG, et al. Effect of a cerebral protection device on brain lesions following transcatheter aortic valve implantation in patients with severe aortic stenosis: the CLEAN-TAVI randomized clinical trial. J Am Med Assoc. 2016;316(6):592–601.
   PubMed Web of Science ®Google Scholar
• Kapadia SR, Kodali S, Makkar R, et al. Protection against cerebral embolism during transcatheter aortic valve replacement. J Am Coll Cardiol. 2017;69(4):367–377.
   PubMed Web of Science ®Google Scholar
• Pagnesi M, Martino EA, Chiarito M, et al. Silent cerebral injury after transcatheter aortic valve implantation and the preventive role of embolic protection devices: A systematic review and meta-analysis. Int J Cardiol. 2016;221:97–106.
   PubMed Web of Science ®Google Scholar
• Buzzatti N, Romano V, De Backer O, et al. Coronary access after repeated transcatheter aortic valve implantation: a glimpse into the future. JACC Cardiovasc Imaging. 2020;13(2):508–515.
   PubMed Web of Science ®Google Scholar
• Yudi MB, Sharma SK, Tang GHL, et al. Coronary angiography and percutaneous coronary intervention after transcatheter aortic valve replacement. J Am Coll Cardiol. 2018;71(12):1360–1378.
   PubMed Web of Science ®Google Scholar
• Goel SS, Ige M, Tuzcu EM, et al. Severe aortic stenosis and coronary artery disease - implications for management in the transcatheter aortic valve replacement era: A comprehensive review. J Am Coll Cardiol. 2013;62(1):1–10.
   PubMed Web of Science ®Google Scholar
• Vilalta V, Asmarats L, Ferreira-Neto AN, et al. Incidence, clinical characteristics, and impact of acute coronary syndrome following transcatheter aortic valve replacement. JACC Cardiovasc Interv. 2018;11(24):2523–2533.
   PubMed Web of Science ®Google Scholar
• Faroux L, Munoz-Garcia E, Serra V, et al. Acute coronary syndrome following transcatheter aortic valve replacement. Circ Cardiovasc Interv. 2020;13:2.
   Web of Science ®Google Scholar
• Jabbour RJ, Tanaka A, Finkelstein A, et al. Delayed coronary obstruction after transcatheter aortic valve replacement. J Am Coll Cardiol. 2018;71(14):1513–1524.
   PubMed Web of Science ®Google Scholar
• Ochiai T, Chakravarty T, Yoon SH, et al. Coronary Access After TAVR. JACC Cardiovasc Interv. 2020;13(6):693–705.
   PubMed Web of Science ®Google Scholar
• de Backer O, Dangas GD, Jilaihawi H, et al. Reduced leaflet motion after transcatheter aortic-valve replacement. N Engl J Med. 2020;382(2):130–139.
   PubMed Web of Science ®Google Scholar
• Makkar RR, Blanke P, Leipsic J, et al. Subclinical leaflet thrombosis in transcatheter and surgical bioprosthetic valves: PARTNER 3 cardiac computed tomography substudy. J Am Coll Cardiol. 2020;75(24):3003–3015.
   PubMed Web of Science ®Google Scholar
• Blackman DJ, Saraf S, MacCarthy PA, et al. Long-term durability of transcatheter aortic valve prostheses. J Am Coll Cardiol. 2019;73(5):537–545.
   PubMed Web of Science ®Google Scholar
• Testa L, Latib A, Brambilla N, et al. Long-term clinical outcome and performance of transcatheter aortic valve replacement with a self-expandable bioprosthesis. Eur Heart J. 2020;41(20):1876–1886.
   PubMed Web of Science ®Google Scholar
• Makkar RR, Fontana G, Jilaihawi H, et al. Possible subclinical leaflet thrombosis in bioprosthetic aortic valves. N Engl J Med. 2015;373(21):2015–2024.
   PubMed Web of Science ®Google Scholar
• Mangieri A, Montalto C, Poletti E, et al. Thrombotic versus bleeding risk after transcatheter aortic valve replacement: JACC review topic of the week. J Am Coll Cardiol. 2019;74(16):2088–2101.
   PubMed Web of Science ®Google Scholar
• Del Trigo M, Muñoz-García AJ, Latib A, et al. Impact of anticoagulation therapy on valve haemodynamic deterioration following transcatheter aortic valve replacement. Heart. 2018;104(10):814–820.
   PubMed Web of Science ®Google Scholar
• Ruile P, Jander N, Blanke P, et al. Course of early subclinical leaflet thrombosis after transcatheter aortic valve implantation with or without oral anticoagulation. Clin Res Cardiol. 2017;106(2):85–95.
   PubMed Web of Science ®Google Scholar
• Dangas GD, Tijssen JGP, Wöhrle J, et al. A controlled trial of rivaroxaban after transcatheter aortic-valve replacement. N Engl J Med. 2020;382(2):120–129.
   PubMed Web of Science ®Google Scholar
• Baumgartner H, Falk V, Bax JJ, et al. ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2017;38(36):2739–2791.
   PubMed Web of Science ®Google Scholar
• Nishimura RA, Otto CM, Bonow RO, et al. AHA/ACC guideline for the management of patients with valvular heart disease: A report of the american college of cardiology/american heart association task force on practice guidelines. Circulation. 2014;129(23). DOI:10.1161/CIR.0000000000000031
   Web of Science ®Google Scholar
• Fetahovic T, Hayman S, Cox S, et al. The prophylactic chimney snorkel technique for the prevention of acute coronary occlusion in high risk for coronary obstruction transcatheter aortic valve replacement/implantation cases. Heart Lung Circ. 2019;28(10):e126–e130.
   PubMed Web of Science ®Google Scholar
• Lederman RJ, Babaliaros VC, Rogers T, et al. Preventing coronary obstruction during transcatheter aortic valve replacement: from computed tomography to BASILICA. JACC Cardiovasc Interv. 2019;12(13):1197–1216.
   PubMed Web of Science ®Google Scholar
• Khan JM, Greenbaum AB, Babaliaros VC, et al. The BASILICA trial: prospective multicenter investigation of intentional leaflet laceration to prevent TAVR coronary obstruction. JACC Cardiovasc Interv. 2019;12(13):1240–1252.
   PubMed Web of Science ®Google Scholar
• Valvo R, Costa G, Barbanti M. How to avoid coronary occlusion during TAVR valve-in-valve procedures. Front Cardiovasc Med. 2019;6. DOI:10.3389/fcvm.2019.00168
   PubMed Web of Science ®Google Scholar
• Petronio AS, Sinning JM, Van MN, et al. Optimal implantation depth and adherence to guidelines on permanent pacing to improve the results of transcatheter aortic valve replacement with the medtronic corevalve system: the CoreValve prospective, international, post-market advance-II study. JACC Cardiovasc Interv. 2015;8(6):837–846.
   PubMed Web of Science ®Google Scholar
• Petronio AS, Angelillis M, De Backer O, et al. Bicuspid aortic valve sizing for transcatheter aortic valve implantation: development and validation of an algorithm based on multi-slice computed tomography. J Cardiovasc Comput Tomogr. 2020;(January):1. DOI:10.1016/j.jcct.2020.01.007
   PubMedGoogle Scholar
• Yoon SH, Lefèvre T, Ahn JM, et al. Transcatheter aortic valve replacement with early- and new-generation devices in bicuspid aortic valve stenosis. J Am Coll Cardiol. 2016;68(11):1195–1205.
   PubMed Web of Science ®Google Scholar
• Mylotte D, Lefevre T, Søndergaard L, et al. Transcatheter aortic valve replacement in bicuspid aortic valve disease. J Am Coll Cardiol. 2014;64(22):2330–2339.
   PubMed Web of Science ®Google Scholar